This product is a recombinant human antibody clone HuMab C that can bind to human RG1 with high affinity. The binding affinity of KD is 33.6 nM.
Figure 1 Anti-tumor effect of ⁷⁰Y labeled RG1 Antibodies: LNCaP tumor bearing animals were injected with ⁷⁰Y labeled antibodies (anti-RG1 antibodies B and C or non-specific IgG, specific activity, 0.5 mCi/mg).
A single dose of ¹²⁵ uCi ⁷⁰Y-labeled RG1 antibody (B.C) was adminis tered i.p. Mice were sacrificed at day 32 and tumors excised and weighed.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0291CQ | Human Anti-RG1 Recombinant Antibody (clone HuMab B) | ELISA, WB, IHC | Human IgG1, κ |
There are currently no Customer reviews or questions for HPAB-0292CQ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.